NYU Langone Health named No. 1 in the nation for quality and patient safety

NYU Langone Health has once again been named No. 1 in the nation for quality and patient safety by Vizient Inc., a leading healthcare performance improvement organization that determines its rankings based on mortality and infection rates, patient experience scores, and other critical quality measures.

Weekly Insulin Efsitora Noninferior to Daily Degludec in Type 1, Type 2 Diabetes

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky for those with type 1 diabetes,

September 11, 2024

BenevolentAI CEO is out after less than a year on the job

BenevolentAI’s CEO Joerg Moeller is stepping down effective immediately, the London biotech said Thursday, in the latest leadership shakeup atop the company. Since going public

October 18, 2024

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

A study led by UCLA Health Jonsson Comprehensive Cancer Center researchers found that using a combination of experimental immunotherapy drugs with chemotherapy significantly improves progression-free

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.